Toxins,
Journal Year:
2024,
Volume and Issue:
16(12), P. 551 - 551
Published: Dec. 19, 2024
Cyanobacteria,
also
known
as
blue-green
algae,
are
a
diverse
phylum
of
photosynthetic,
Gram-negative
bacteria
and
one
the
largest
microbial
taxa.
These
organisms
produce
cyanotoxins,
which
secondary
metabolites
that
can
have
significant
impacts
on
both
human
health
environment.
While
toxins
like
Microcystins
Cylindrospermopsins
well-documented
been
extensively
studied,
other
including
those
produced
by
Lyngbya
Nostoc,
remain
underexplored.
lesser-known
cause
various
issues
in
humans,
neurotoxicity,
hepatotoxicity,
dermatotoxicity,
each
through
distinct
mechanisms.
Moreover,
recent
studies
shown
cyanobacteria
be
aerosolized
transmitted
air
over
long
distances,
providing
an
additional
route
for
exposure
to
their
harmful
effects.
However,
it
remains
area
requires
much
more
investigation
accurately
assess
risks
develop
appropriate
public
guidelines.
In
addition
direct
toxins,
lead
algal
blooms,
pose
further
wildlife
health,
global
concern.
There
is
limited
knowledge
about
these
highlighting
need
research
understand
clinical
manifestations
improve
society’s
preparedness
associated
risks.
This
work
aims
review
existing
literature
underexplored
with
intoxication,
elucidate
relevance,
address
challenges
cyanobacterial
research,
provide
guidance
mitigating
adverse
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(10), P. 2052 - 2052
Published: Oct. 11, 2024
The
process
of
aging
leads
to
a
progressive
decline
in
the
immune
system
function,
known
as
immunosenescence,
which
compromises
both
innate
and
adaptive
responses.
This
includes
impairments
phagocytosis
decreased
production,
activation,
function
T-
B-lymphocytes,
among
other
effects.
Bacteria
exploit
immunosenescence
by
using
various
virulence
factors
evade
host’s
defenses,
leading
severe
often
life-threatening
infections.
manuscript
explores
complex
relationship
between
bacterial
virulence,
focusing
on
underlying
mechanisms
that
increase
vulnerability
infections
elderly.
Additionally,
it
discusses
how
machine
learning
methods
can
provide
accurate
modeling
interactions
weakened
mechanisms,
guiding
development
personalized
interventions.
vaccines,
novel
antibiotics,
antivirulence
therapies
for
multidrug-resistant
bacteria,
well
investigation
potential
immune-boosting
therapies,
are
promising
strategies
this
field.
Future
research
should
focus
approaches
be
integrated
with
immunological,
microbiological,
clinical
data
develop
interventions
improve
outcomes
growing
elderly
population.
Journal of Separation Science,
Journal Year:
2024,
Volume and Issue:
47(23)
Published: Dec. 1, 2024
ABSTRACT
Antimicrobial
peptides
(AMPs)
are
excellent
promising
candidates
for
biomedical
applications
owing
to
their
structural
properties,
high
biocompatibility,
good
biodegradability,
and
functional
diversity.
Unlike
conventional
antibiotics,
AMPs
have
been
shown
broad‐spectrum
antimicrobial
activity
toward
Gram‐positive/negative
bacteria,
as
well
antifungal
antiviral
activity.
These
also
found
be
cytotoxic
sperm
cancer
cells.
A
range
of
has
isolated
from
various
organisms,
such
fungi,
plants,
animals.
This
review
summarizes
the
latest
studies
on
AMPs,
covering
isolation,
purification,
characterization
potential
beyond.
Drug Development Research,
Journal Year:
2025,
Volume and Issue:
86(1)
Published: Feb. 1, 2025
ABSTRACT
The
emergence
of
drug‐resistant
bacteria,
often
referred
to
as
“superbugs,”
poses
a
profound
and
escalating
challenge
global
health
systems,
surpassing
the
capabilities
traditional
antibiotic
discovery
methods.
As
resistance
mechanisms
evolve
rapidly,
need
for
innovative
solutions
has
never
been
more
critical.
This
review
delves
into
transformative
role
AI‐driven
methodologies
in
development,
particularly
targeting
bacterial
strains
(DRSBs),
with
an
emphasis
on
understanding
their
action.
AI
algorithms
have
revolutionized
process
by
efficiently
collecting,
analyzing,
modeling
complex
datasets
predict
both
effectiveness
potential
antibiotics
resistance.
These
computational
advancements
enable
researchers
identify
promising
candidates
unique
that
effectively
bypass
conventional
pathways.
By
specifically
critical
processes
or
disrupting
essential
cellular
components,
these
AI‐designed
offer
robust
combating
even
most
resilient
strains.
application
design
represents
paradigm
shift,
enabling
rapid
precise
identification
novel
compounds
tailored
approach
not
only
accelerates
drug
development
timeline
but
also
enhances
precision
superbugs,
significantly
improving
therapeutic
outcomes.
Furthermore,
underlying
is
crucial
optimizing
clinical
efficacy
devising
proactive
strategies
prevent
further
poised
play
pivotal
fight
against
antimicrobial
leveraging
power
artificial
intelligence,
are
opening
new
frontiers
effective
treatments,
ensuring
sustainable
response
growing
threat
bacteria.
BMC Veterinary Research,
Journal Year:
2025,
Volume and Issue:
21(1)
Published: March 13, 2025
Abstract
Background
The
liver-expressed
antimicrobial
peptide
2
(LEAP2)
family
is
an
important
group
of
peptides
(AMPs)
involved
in
vertebrate
defence
against
bacterial
infections.
However,
research
on
LEAP2
amphibians
still
its
infancy.
Results
This
study
aimed
to
explore
the
role
Chinese
spiny
frog
(
Quasipaa
spinosa
).
cDNA
gene
QsLEAP2
)
was
cloned
from
a
frog.
protein
comprises
signal
peptide,
prodomain,
and
mature
peptide.
Sequence
analysis
indicated
that
member
amphibian
cluster
closely
related
African
clawed
Xenopus
laevis
Expression
detected
various
tissues,
with
liver
exhibiting
highest
expression.
Following
infection
Aeromonas
hydrophila
,
expression
significantly
upregulated
spleen,
lungs,
kidneys,
liver,
gut.
synthetic
exhibited
selective
activity
several
strains
vitro.
It
disrupted
membrane
integrity
hydrolysed
genomic
DNA,
bactericidal
effects
specific
species.
Furthermore,
induced
chemotaxis
RAW264.7
murine
leukemic
monocytes/macrophages,
enhancing
their
phagocytic
respiratory
bursts.
Docking
simulations
revealed
interaction
between
QsMOSPD2.
Conclusions
These
findings
provide
new
insights
into
immune
system.
SLAS DISCOVERY,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100232 - 100232
Published: April 1, 2025
Antimicrobial
resistance
(AMR)
develops
into
a
worldwide
health
emergency
through
genetic
and
biochemical
adaptations
which
enable
microorganisms
to
resist
antimicrobial
treatment.
β-lactamases
(blaNDM,
blaKPC)
efflux
pumps
(MexAB-OprM)
working
with
mobile
elements
facilitate
fast
proliferation
of
multidrug-resistant
(MDR)
exttreme
drug-resistant
(XDR)
phenotypes
thus
creating
major
concerns
for
healthcare
systems
community
as
well
the
agricultural
sector.
The
review
dissimilarly
unifies
molecular
pathways
public
implications
study
epidemiological
data
monitoring
approaches
innovative
therapeutic
solutions.
Previous
studies
separating
their
attention
between
genetics
clinical
outcomes
have
been
combined
our
approach
delivers
an
all-encompassing
analysis
AMR.
report
investigates
mechanisms
feature
enzymatic
degradation
pump
overexpression
together
target
modification
horizontal
gene
transfer
because
these
factors
represent
important
contributors
present-day
AMR
developments.
This
effects
on
hospital
environments
where
it
affects
pathogens
including
MRSA,
carbapenem-resistant
Klebsiella
pneumoniae,
Pseudomonas
aeruginosa.
document
explores
modern
management
methods
that
comprise
WHO
GLASS
surveillance
three
strategies
such
CRISPR-modified
genome
editing
bacteriophage
treatments
along
peptides
artificial
intelligence
diagnostic
tools.
resolution
needs
complete
scientific
global
operational
alongside
state-of-the-art
approaches.
Worldwide
infection
burden
requires
both
enhanced
prevention
procedures
next-generation
reduce
cases
effectively.